1. Home
  2. QTTB
  3. QTTB News

Latest Q32 Bio Inc. Common Stock (QTTB) News on November 23, 2024

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024

PR Newswire

a month ago

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024

Share on Social Networks: